Skip to main content
. Author manuscript; available in PMC: 2022 Feb 10.
Published in final edited form as: J Natl Compr Canc Netw. 2022 Feb;20(2):136–143. doi: 10.6004/jnccn.2021.7040

Table 4.

Descriptive Statistics for Patient-Reported Outcome Measures across Time Points

Variable* Usual Care M (SD) Intervention M (SD)
Baseline, N=120
 FACT-B 96.45 (19.57) 101.36 (16.64)
 HADS-Anxiety Subscale 7.38 (3.93) 5.95 (3.37)
 HADS-Depression Subscale 5.47 (3.57) 5.16 (3.59)
6 Weeks, N=107
 FACT-B 98.94 (19.27) 102.01 (17.90)
 HADS-Anxiety Subscale 6.40 (4.33) 5.79 (3.89)
 HADS-Depression Subscale 5.13 (3.21) 5.37 (3.70)
12 Weeks, N=95
 FACT-B 99.32 (20.90) 101.03 (18.58)
 HADS-Anxiety Subscale 6.26 (4.46) 5.82 (3.42)
 HADS-Depression Subscale 5.04 (3.49) 5.67 (4.12)
18 Weeks, N=85
 FACT-B 97.95 (19.94) 99.77 (20.72)
 HADS-Anxiety Subscale 7.07 (4.13) 5.49 (3.42)
 HADS-Depression Subscale 5.91 (3.60) 5.75 (4.43)
24 Weeks, N=79
 FACT-B 96.33 (20.76) 101.15 (19.35)
 HADS-Anxiety Subscale 7.08 (4.88) 5.87 (4.42)
 HADS-Depression Subscale 5.31 (3.83) 4.83 (3.71)
*

Note: FACT-B=Functional Assessment of Cancer Therapy-Breast; HADS=Hospital Anxiety and Depression Scale